Skip Navigation



Europace Advance Access published online on March 15, 2007
Europace, doi:10.1093/europace/eum029
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
9/5/267    most recent
eum029v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bakir, I.
Right arrow Articles by Wellens, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bakir, I.
Right arrow Articles by Wellens, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

CASE REPORT

A novel treatment strategy for therapy refractory ventricular arrhythmias in the setting of arrhythmogenic right ventricular dysplasia

Ihsan Bakir1,*, Pedro Brugada2, Andrea Sarkozy2, Catherine Vandepitte3 and Francis Wellens1

1 OLV Clinic, Cardiovascular and Thoracic Surgery Department, Moorselbaan 164, 9300 Aalst, Belgium; 2 OLV Clinic, Cardiovascular Research and Teaching Institute, Aalst, Belgium; 3 OLV Clinic, Anaesthesiology and Resuscitation Department, Aalst, Belgium

Arrhythmogenic right ventricular dysplasia (ARVD) is a major cause of ventricular tachycardia and cardiac arrest in young adults. The ideal management of this genetic disorder is individual. The treatment options are antiarrhythmic drug therapy, transcatheter radiofrequency catheter ablation, implantable cardioverter defibrillator therapy, and surgical treatment [Kies P, Bootsma M, Bax J, Schalij MJ, van der Wall EE. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. Heart Rhythm 2006;3:225–34; Verma A, Kilicaslan F, Schweikert RA et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 2005;111:3209–16]. In the following, we describe a unique case of a young patient, presenting with therapy refractory ventricular arrhythmias in the setting of ARVD, who following failed catheter ablations, has been successfully treated with beating heart cryoablation.

Key Words: Arrhythmogenic right ventricular dysplasia, Beating heart surgery, Cryoablation, Radiofrequency catheter ablation, Sternotomy

* Corresponding author. Tel: +90 216 3727474; fax: +90 216 3734427. E-mail address: ihsanbak{at}yahoo.com

Dr. Bakir is affiliated with Siyami Ersek Cardiovascular Surgery Center, Istanbul, Turkey.

Manuscript submitted 19 August 2006. Accepted after revision 31 January 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al.
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
Europace, June 1, 2009; 11(6): 771 - 817.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.